First-Line Treatment for Plaque Psoriasis Covering Less Than 10% of Body Surface Area
For plaque psoriasis covering less than 10% of the body surface area where moisturizers have failed, topical corticosteroids are the recommended first-line treatment due to their rapid efficacy and favorable safety profile. 1, 2
Treatment Algorithm
First-Line Options:
Topical Corticosteroids
Vitamin D Analogs (alternative or combination)
Second-Line Options (if inadequate response to first-line):
Combination Therapy
Coal Tar Preparations
- Start with concentrations of 0.5-1.0% crude coal tar in petroleum jelly
- Increase concentration gradually to a maximum of 10% 1
Topical Dithranol (Anthralin)
- Start at 0.1-0.25% concentration
- Increase in doubling concentrations as tolerated
- Can be used in "short contact mode" (15-45 minutes daily) 1
Clinical Considerations
Advantages of Topical Corticosteroids:
- Rapid onset of action (improvement within 1-2 weeks) 7
- Simple to use and relatively inexpensive 7
- Lower incidence of local adverse events compared to vitamin D analogs 8
Advantages of Vitamin D Analogs:
- Better maintenance of therapeutic effect after discontinuation 1
- Lower risk of skin atrophy with long-term use 8
- Effective in 6-8 weeks of treatment 7
Important Caveats:
- Limit use of potent corticosteroids to 4 weeks to minimize risk of skin atrophy 2
- For sensitive areas (face, intertriginous areas), use low-potency steroids or calcineurin inhibitors 1, 2
- Regular clinical review is essential when using corticosteroids 1
- Periods of alternative treatment should be employed throughout the year 1
- For long-term management, consider rotation or sequential therapy to minimize side effects 6
Monitoring:
- Evaluate treatment response after 4 weeks 2
- Monitor for local adverse effects:
- Corticosteroids: skin atrophy, telangiectasia, striae
- Vitamin D analogs: irritation, burning sensation
- If inadequate response after 4-8 weeks, consider adding phototherapy or switching to another topical agent 2
The evidence strongly supports topical corticosteroids as the most effective first-line treatment for limited plaque psoriasis, with vitamin D analogs as an excellent alternative or complementary therapy. The combination of both agents provides superior efficacy with a better safety profile than either agent used alone 5.